![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Hubei Biocause Heilen Pharmaceutical Co., Ltd. Jingmen City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Ibuprofen, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2002-099 - Rev 07
This Chemical Type CEP, issued on December 07, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 721 associated with this CEP further emphasizes